satigrel has been researched along with Recrudescence in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishima, M; Hirai, S; Ikeda, Y; Kameyama, M; Maruyama, S; Matsuda, T; Shinohara, Y; Tohgi, H; Uchiyama, S | 1 |
1 trial(s) available for satigrel and Recrudescence
| Article | Year |
|---|---|
A randomized trial of E5510 versus aspirin in patients with transient ischemic attacks. The Japanese E5510 TIA study-1 (JETS-1) Group.
Topics: Aged; Aspirin; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Treatment Outcome | 1995 |